HAVCR2 and gastrointestinal stromal tumor: Moreover, LAG3 [35] and Tim-3 [35, 108] are present in tumor-infiltrating lymphocytes, suggesting that they may participate in immune escape of GIST and are the potential targets for immunotherapy.